Dr. Sierro selects the treatment modality — or combination — based on the precise diagnosis, severity of hair loss, patient health status, and treatment goals. The following evidence-based options are available at Kare Plastic Surgery & Skin Health Center.
01
PRP (Platelet-Rich Plasma) for Hair Loss
PRP hair restoration is the most established and most extensively studied non-surgical biological treatment for androgenetic alopecia and alopecia areata. The procedure begins with a small blood draw from the patient’s arm, which is processed in a medical-grade centrifuge to concentrate the platelet fraction — producing a plasma preparation that contains up to 5–10 times the platelet concentration found in normal whole blood. This platelet-rich plasma is then injected into the scalp at the level of the hair follicle bulge — the anatomical zone where follicular stem cells reside — delivering a concentrated dose of growth factors including PDGF, TGF-β, VEGF, EGF, IGF-1, and FGF.
These growth factors stimulate follicular stem cell activity, prolong the anagen (growth) phase of the hair cycle, promote neovascularization of the perifollicular capillary network, and rescue miniaturizing follicles from progressive DHT-mediated atrophy. A 2020 systematic review of six randomized controlled trials (92 patients) confirmed PRP’s positive effect on female pattern hair loss with significant increases in hair thickness and density. A 2020 meta-analysis found significantly increased hair counts per cm² in PRP-treated patients versus controls, with improvements in both density and shaft diameter. A 2020 study confirmed PRP as a “safe, effective, steroid-sparing, and suitable alternative in alopecia areata.”
Best For: Male and female androgenetic alopecia, alopecia areata, telogen effluvium, postpartum hair loss; mild to moderate stages with functioning follicles; in combination with Minoxidil, Dutasteride, and exosomes
02
Exosome Therapy for Hair Restoration
Exosome hair therapy represents the frontier of biological regenerative medicine for hair loss — and the most significant advance in non-surgical hair restoration science since the introduction of PRP. Exosomes are nano-sized extracellular vesicles (40–150nm) derived from mesenchymal stem cells that carry a sophisticated biological payload: thousands of growth factors, cytokines, mRNA transcripts, and microRNA molecules that directly regulate cell proliferation, differentiation, and tissue repair at the molecular level.
When injected into the scalp or delivered through microneedling channels, exosomes signal dormant or miniaturizing follicles to re-enter active growth, stimulate Wnt/β-catenin and Sonic Hedgehog signaling pathways that are essential for hair follicle cycling, promote VEGF-mediated neovascularization of the perifollicular network, and suppress inflammatory signals that drive follicular miniaturization. Published data confirm that exosome therapy produces hair density improvements superior to PRP in head-to-head comparisons, with longer-lasting results and a more potent anti-inflammatory effect — making it particularly valuable for patients with alopecia areata, early scarring alopecia, and treatment-resistant androgenetic alopecia where PRP alone has produced inadequate response.
Best For: Treatment-resistant androgenetic alopecia, alopecia areata, advanced hair thinning, post-chemotherapy hair recovery; maximum biological effect when combined with PRP and microneedling
03
Microneedling for Hair Loss
Scalp microneedling uses a medical-grade device with fine needles (0.5–1.5mm) to create controlled micro-injuries in the scalp dermis, stimulating wound healing responses that include collagen production, growth factor release, and increased dermal papilla cell proliferation — all of which support follicular activity and hair growth. Microneedling also dramatically increases the permeability of the scalp to topically applied or injected agents, making it the ideal delivery method for combining with PRP, exosomes, or topical Minoxidil to amplify their penetration and follicular uptake.
A 2013 randomized controlled trial published in the Journal of Cutaneous and Aesthetic Surgery found that microneedling combined with Minoxidil produced a 4-fold greater increase in hair count than Minoxidil alone. When combined with PRP or exosomes at Kare, microneedling creates a synergistic biological amplification — the micro-injuries providing the wound healing stimulus and the injected biological agents providing the cellular fuel for follicular regeneration. Dr. Sierro uses microneedling as a component of her combination hair restoration protocols and as a standalone scalp treatment for patients seeking a non-injectable maintenance option.
Best For: Combination with PRP or exosomes for maximum efficacy; maintenance between PRP sessions; patients who prefer minimal-injection protocols; delivery vehicle for topical Minoxidil enhancement
04
Dutasteride for Hair Loss
Dutasteride is a dual 5-alpha reductase inhibitor (blocking both Type I and Type II 5-AR isoenzymes) that reduces serum and scalp DHT levels by more than 90% — significantly more complete DHT suppression than Finasteride, which inhibits only Type II 5-AR and reduces DHT by approximately 65–70%. This more complete androgenic blockade makes Dutasteride the most pharmacologically potent oral treatment available for androgenetic alopecia in men, though it is prescribed off-label for hair loss as it is FDA-approved only for benign prostatic hyperplasia.
Head-to-head randomized controlled trial data confirm Dutasteride’s superiority over Finasteride for male pattern baldness: a large Korean multicenter trial demonstrated significantly greater improvement in hair counts and global photographic assessment with Dutasteride 0.5mg compared to Finasteride 1mg at 24 weeks. Dutasteride is also increasingly used off-label in women with hyperandrogenism-driven female pattern hair loss and in patients with PCOS-associated alopecia, under careful physician supervision. Dr. Sierro evaluates each patient’s hormonal profile, reproductive status, and comorbidities before prescribing Dutasteride, and monitors for sexual side effects that, while less common than with Finasteride, require clinical attention.
Best For: Men with moderate to advanced androgenetic alopecia seeking maximum pharmacologic DHT suppression; patients who have had inadequate response to Finasteride; women with documented hyperandrogenism (under physician monitoring)
05
Minoxidil (Topical & Oral)
Minoxidil is the only FDA-approved topical treatment for both male and female pattern hair loss and remains a cornerstone of non-surgical hair restoration at every stage of treatment intensity. Its mechanism of action involves vasodilation of scalp blood vessels (Minoxidil is a potassium channel opener), increasing perifollicular blood flow and nutrient delivery, prolonging the anagen phase, and stimulating follicular keratinocyte proliferation. Topical Minoxidil (2% for women, 5% for men) applied once or twice daily produces measurable hair density improvements in 40–60% of users within 6–12 months of consistent use.
Low-dose oral Minoxidil — at doses of 0.5–2.5mg daily, far below the 10–40mg doses used for hypertension — has emerged in recent years as a highly effective and better-tolerated alternative to topical Minoxidil for patients with scalp sensitivity, application compliance challenges, or inadequate response to topical formulations. Multiple published case series and randomized trials confirm significant hair density improvements with low-dose oral Minoxidil in both male and female pattern hair loss, with a favorable side effect profile at these low doses. Dr. Sierro prescribes both topical and oral Minoxidil formulations and designs combined regimens that integrate Minoxidil with PRP and exosome treatments for maximum synergistic effect.
Best For: First-line pharmacologic treatment for all androgenetic alopecia stages in men and women; maintenance between PRP sessions; combination with Dutasteride for maximum medical management of male pattern baldness
06
FUE Hair Transplant (Follicular Unit Extraction)
For patients whose androgenetic alopecia has progressed to the point where existing follicles cannot be reliably resurrected by biological treatments — because miniaturization has advanced to the point of complete follicular loss in the affected zones — surgical hair restoration through follicular unit extraction (FUE) provides the only option for restoring hair density in permanently bald areas. FUE harvests individual follicular units from the androgen-resistant donor zone of the posterior scalp using a small punch device (0.8–1.0mm), then transplants these DHT-resistant follicles into recipient sites created in the bald or thinning zones of the scalp.
Dr. Karamanoukian performs FUE hair transplantation with the same anatomical precision and surgical discipline he applies to all procedures at Kare. His understanding of scalp blood supply, follicular unit angulation, natural hair growth direction variability across scalp zones, and wound healing biology — knowledge derived from his UCLA surgical training and two decades of reconstructive scalp surgery — translates directly into graft viability, natural-appearing results, and minimal transection rates. FUE at Kare Plastic Surgery is performed under local anesthesia with oral sedation as an outpatient procedure. Most patients return to normal activities within 5–7 days and see the first signs of transplanted hair growth at 3–4 months, with full results visible at 12–18 months. PRP is administered intraoperatively and at follow-up sessions to accelerate graft survival and optimize the growth of transplanted follicles.
Best For: Advanced androgenetic alopecia with established bald zones; patients who want permanent restoration not achievable with non-surgical methods; hairline restoration and crown density; combined with post-operative PRP for maximum graft survival